Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis
PLOS ONE · 16.08.2023 · 18 (8) · e0289975
DOI: 10.1371/journal.pone.0289975 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 16.08.2023. Verfasst von Shaghayegh Khanmohammadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cryosurgery, Liver Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Liver metastasis is present in a wide range of malignancies, with colorectal cancer as the most common site. Several minimally invasive treatments have been suggested for managing hepatic metastases, and cryoablation is among them, yet not widely used. In this systematic review, we aimed to assess the effectiveness of percutaneous cryoablation in all types of liver metastases.
Methods
A systematic search was performed in international databases, including PubMed, Scopus, Embase, and Web of Science, to find relevant studies reporting outcomes for percutaneous cryoablation in liver metastasis patients. In addition to baseline features such as mean age, gender, metastasis origin, and procedure details, procedure outcomes, including overall survival, local recurrence, quality of life (QoL), and complications, were extracted from the studies. Random-effect meta-analysis was performed to calculate the mean difference (MD) and 95% confidence interval for comparison of QoL.
Results
We screened 2131 articles. Fifteen studies on 692 patients were included. Mean overall survival ranged from 14.5–29 months. The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Population Sciences Institute, Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Radiology, Pardis Noor Medical Imaging Center, Tehran, Iran.
ORCID-Profile: Shahram Akhlaghpoor
Zitieren
APA
Khanmohammadi, S., Behnoush, A. H., & Akhlaghpoor, S. (2023). Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis. PLOS ONE, 18(8), e0289975. https://doi.org/10.1371/journal.pone.0289975
Vancouver
Khanmohammadi S, Behnoush AH, Akhlaghpoor S. Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis. PLOS ONE. 2023;18(8):e0289975. doi:10.1371/journal.pone.0289975
BibTeX
@article{Khanmohammadi2023,
author = {Khanmohammadi, Shaghayegh and Behnoush, Amir Hossein and Akhlaghpoor, Shahram},
title = {Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {8},
pages = {e0289975},
doi = {10.1371/journal.pone.0289975}
}
EUVIMED